None
EN
Edwards Lifesciences: Strong Execution, But Little Room For Error At $90
[]
All Articles on Seeking Alpha
EW is a SellMaxell Agustin Aguiran is an equity research analyst, quantitative researcher, and Founder & Principal Consultant at Dragon Analytics.
His work includes developing evidence-based investment research, forecasting models, and analytical solutions that help investors and businesses interpret complex data, evaluate opportunities, and make better-informed decisions.
I am not receiving compensation for it (other than from Seeking Alpha).
Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole.
Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.